Zomedica Pharmaceuticals Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Public

  • Employees
  • 144

Employees

  • Stock Symbol
  • ZOM

Stock Symbol

  • Investments
  • 7

  • Share Price
  • $0.14
  • (As of Friday Closing)

Zomedica Pharmaceuticals General Information

Description

Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is currently focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments: Diagnostic & Therapeutics. It earns the majority of revenue from the therapeutics segment.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Other Healthcare Services
Other Industries
Diagnostic Equipment
Stock Exchange
ASE
Corporate Office
  • 100 Phoenix Drive
  • Suite 125
  • Ann Arbor, MI 48108
  • United States
+1 (734) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zomedica Pharmaceuticals Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.14 $0.14 $0.12 - $0.24 $132M 980M 5.29M -$0.04

Zomedica Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 31-Dec-2023 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 91,731 91,731 42,073 30,404
Revenue 25,186 25,186 18,930 4,133
EBITDA (34,845) (34,845) (18,039) (19,929)
Net Income (34,529) (34,529) (17,015) (18,384)
Total Assets 253,197 253,197 279,610 280,400
Total Debt 2,730 2,730 1,738 1,379
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Zomedica Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Zomedica Pharmaceuticals‘s full profile, request access.

Request a free trial

Zomedica Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focu
Other Healthcare Services
Ann Arbor, MI
144 As of 2023
000.00
00000000 000.00

00000

ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
0000000000 000000000
Loveland, CO
000 As of 0000
00000
000000000000

000000

rem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor inc
0000000000 000000000
Emeryville, CA
00.000 0000-00-00
00000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Zomedica Pharmaceuticals Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Heska Private Equity-Backed Loveland, CO 000 00000 000000000000
Grifols Diagnostic Solutions Corporate Backed or Acquired Emeryville, CA 00000000000
Ocugen Corporation Malvern, PA 00 000.00 000000000 000.00
Idexx Laboratories Formerly VC-backed Westbrook, ME 00000 00000 000000000 00000
Antech Diagnostics Corporation Pasadena, CA 0000
You’re viewing 5 of 5 competitors. Get the full list »

Zomedica Pharmaceuticals Executive Team (12)

Name Title Board Seat Contact Info
Lary Heaton President
Peter Donato Chief Financial Officer
Anthony Blair Chief Operating Officer, Operations
Karen DeHaan-Fullerton General Counsel & Corporate Secretary
You’re viewing 4 of 12 executive team members. Get the full list »

Zomedica Pharmaceuticals Board Members (8)

Name Representing Role Since
Johnny Powers Ph.D Zomedica Pharmaceuticals Board Member 000 0000
Robert Cohen Zomedica Pharmaceuticals Board Member 000 0000
Rodney Williams Zomedica Pharmaceuticals Director and Chairman of Governance Committee 000 0000
Sean Whelan Self Board Member 000 0000
You’re viewing 4 of 8 board members. Get the full list »

Zomedica Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zomedica Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Zomedica Pharmaceuticals‘s full profile, request access.

Request a free trial

Zomedica Pharmaceuticals Investments & Acquisitions (7)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Qorvo Biotechnologies 05-Oct-2023 0000000000 Other Healthcare Technology Systems 0000 0000
VetGuardian 05-Sep-2023 0000000000 Monitoring Equipment 0000 0000
Assisi Animal Health 18-Jul-2022 0000000000 Other Consumer Durables 0000 0000
Revo Squared 06-Jul-2022 0000000000 Diagnostic Equipment 0000000 0
VetGuardian 19-May-2022 Corporate 000 Monitoring Equipment
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

Zomedica Pharmaceuticals Subsidiaries (5)

Company Name Industry Location Founded
VetGuardian Monitoring Equipment Elyria, OH 2015
Assisi Animal Health Other Consumer Durables New Vernon, NJ 0000
Pulse Veterinary Technologies Other Consumer Durables Alpharetta, GA 0000
Revo Squared Diagnostic Equipment Marietta, GA 0000
Qorvo Biotechnologies Other Healthcare Technology Systems Greensboro, NC
To view Zomedica Pharmaceuticals’s complete subsidiaries history, request access »

Zomedica Pharmaceuticals ESG

Risk Overview

Risk Rating

Updated October, 26, 2022

34.91 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 14,912

Rank

00.00

Percentile

Healthcare

Industry

00 of 616

Rank

00.00

Percentile

Medical Devices

Subindustry

00 of 221

Rank

00.0

Percentile

To view Zomedica Pharmaceuticals’s complete esg history, request access »

Zomedica Pharmaceuticals FAQs

  • When was Zomedica Pharmaceuticals founded?

    Zomedica Pharmaceuticals was founded in 2015.

  • Where is Zomedica Pharmaceuticals headquartered?

    Zomedica Pharmaceuticals is headquartered in Ann Arbor, MI.

  • What is the size of Zomedica Pharmaceuticals?

    Zomedica Pharmaceuticals has 144 total employees.

  • What industry is Zomedica Pharmaceuticals in?

    Zomedica Pharmaceuticals’s primary industry is Other Healthcare Services.

  • Is Zomedica Pharmaceuticals a private or public company?

    Zomedica Pharmaceuticals is a Public company.

  • What is Zomedica Pharmaceuticals’s stock symbol?

    The ticker symbol for Zomedica Pharmaceuticals is ZOM.

  • What is the current stock price of Zomedica Pharmaceuticals?

    As of 12-Apr-2024 the stock price of Zomedica Pharmaceuticals is $0.14.

  • What is the current market cap of Zomedica Pharmaceuticals?

    The current market capitalization of Zomedica Pharmaceuticals is $132M.

  • What is Zomedica Pharmaceuticals’s current revenue?

    The trailing twelve month revenue for Zomedica Pharmaceuticals is $25.2M.

  • Who are Zomedica Pharmaceuticals’s competitors?

    Heska, Grifols Diagnostic Solutions, Ocugen, Idexx Laboratories, and Antech Diagnostics are competitors of Zomedica Pharmaceuticals.

  • What is Zomedica Pharmaceuticals’s annual earnings per share (EPS)?

    Zomedica Pharmaceuticals’s EPS for 12 months was -$0.04.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »